Phio Pharmaceuticals Corp.
PHIO
$1.99
-$0.10-4.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.00K | 43.00K | 39.00K | 52.00K | 15.00K |
| Change in Net Operating Assets | -425.00K | 451.00K | 216.00K | -481.00K | 53.00K |
| Cash from Operations | -2.54M | -1.28M | -1.37M | -1.95M | -1.78M |
| Capital Expenditure | -3.00K | -2.00K | -1.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 9.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -2.00K | 8.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.00K | 9.17M | 1.36M | 2.65M | -- |
| Repurchase of Common Stock | -- | -- | -1.00K | -1.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40.00K | 9.17M | 1.36M | 2.65M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.50M | 7.90M | -8.00K | 692.00K | -1.78M |